Kurzrock, R., Okamura, R., Kato, S., Lee, S., Jimenez, R. E., & Sicklick, J. K. ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationKurzrock, Razelle, Ryosuke Okamura, Shumei Kato, Suzanna Lee, Rebecca E. Jimenez, and Jason K. Sicklick. ARID1A Alterations Function as a Biomarker for Longer Progression-free Survival After Anti-PD-1/PD-L1 Immunotherapy. BMJ Publishing Group.
MLA (9th ed.) CitationKurzrock, Razelle, et al. ARID1A Alterations Function as a Biomarker for Longer Progression-free Survival After Anti-PD-1/PD-L1 Immunotherapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.